To assess disease maintenance in the absence of Raptor (mTORC1) in vitro, CLL-like co-cultures were treated with interferon β (IFNβ) to activate the TLR3 receptor. The gene discussed is IFNB1; the disease is B-cell chronic lymphocytic leukemia.